Patent ID: 8545844

Claim:
A humanized antibody that binds to human interleukin-22 receptor alpha (IL-22RA) wherein said humanized antibody comprises: a) a heavy chain variable domain comprising H-CDR1, H-CDR2, and H-CDR3, said H-CDR1, H-CDR2, and H-CDR3 consisting of amino acid sequences of SEQ ID NOs: 1, 2 and 3, respectively; and b) a light chain variable domain comprising L-CDR1, L-CDR2, and L-CDR3, said L-CDR1, L-CDR2, and L-CDR3 consisting of amino acid sequences of SEQ ID NOs: 4, 5, and 6, respectively, or consisting of amino acid sequences of SEQ ID NOs: 4, 5 and 7, respectively.